Efficacy Evaluation of Virus Clearance of SYN023 in A Murine Rabies Model — China, 2025
These findings suggest that SYN023 could serve as a promising therapeutic agent for rabies PEP, particularly in cases in which treatment initiation is delayed. This study provides a scientific basis for future clinical trials aimed at improving rabies treatment protocols.
Authors
- Qian Liu (ORCID: https://orcid.org/0000-0002-8078-1075)
- Si Liu (ORCID: https://orcid.org/0000-0002-5795-0782)
- Minghui Zhang (ORCID: https://orcid.org/0000-0002-6158-7605)
- Shuqing Liu (ORCID: https://orcid.org/0000-0002-9412-3436)
- Wuyang Zhu (ORCID: https://orcid.org/0000-0002-7480-3207)
- Pengcheng Yu
- Xiaoyan Tao
- Yixiang Ma (ORCID: https://orcid.org/0009-0009-8371-2882)
- Z Y Fang (ORCID: https://orcid.org/0000-0001-7878-8553)
Institutions
- Peking University (CN)
- Peking University First Hospital (CN)
- National Institute for Viral Disease Control and Prevention (CN)
Publication Details
- Journal
- China CDC Weekly
- Published
- 2025-01-01
- DOI
- https://doi.org/10.46234/ccdcw2025.209
- Primary Topic
- Rabies epidemiology and control
- Type
- article
- Field-Weighted Citation Impact
- 0.00